Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Monolaurin, a monoglyceride derived from lauric acid (found in coconut oil), has attracted attention for its potential antiviral properties. Laboratory studies have demonstrated that monolaurin can disrupt the lipid membranes of certain enveloped viruses, such as herpes simplex virus (HSV), influenza, and HIV, rendering them inactive. This mechanism is thought to result from monolaurin's ability to solubilize the phospholipid bilayer of viral envelopes, leading to viral disintegration. Some in vitro (test tube) research has also shown monolaurin to inhibit replication of viruses and reduce infectivity.

Despite these promising laboratory results, there is limited evidence from clinical trials in humans to support the use of monolaurin as a treatment for viral infections. Most available studies are preclinical, and few have progressed to well-controlled human trials. Thus, while the theoretical basis and in vitro findings are encouraging, they do not directly establish efficacy or safety in real-world clinical scenarios. The ingredient is sometimes used in alternative and integrative medicine circles for viral infections, based on its antimicrobial profile, but this is not yet substantiated by robust human data.

In summary, monolaurin's use for viral infections is supported by laboratory research, but lacks strong clinical validation. More human studies are needed to confirm its effectiveness and safety for this purpose.

More about monolaurin
More about Infection (viral)

Other ingredients used for Infection (viral)

Other health conditions supported by monolaurin

Products containing monolaurin